![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:ELK4-HDAC3 (FusionGDB2 ID:HG2005TG8841) |
Fusion Gene Summary for ELK4-HDAC3 |
![]() |
Fusion gene information | Fusion gene name: ELK4-HDAC3 | Fusion gene ID: hg2005tg8841 | Hgene | Tgene | Gene symbol | ELK4 | HDAC3 | Gene ID | 2005 | 8841 |
Gene name | ETS transcription factor ELK4 | histone deacetylase 3 | |
Synonyms | SAP1 | HD3|KDAC3|RPD3|RPD3-2 | |
Cytomap | ('ELK4')('HDAC3') 1q32.1 | 5q31.3 | |
Type of gene | protein-coding | protein-coding | |
Description | ETS domain-containing protein Elk-4ELK4, ETS transcription factorELK4, ETS-domain protein (SRF accessory protein 1)SAP-1serum response factor accessory protein 1 | histone deacetylase 3SMAP45 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | O15379 | |
Ensembl transtripts involved in fusion gene | ENST00000289703, ENST00000357992, ENST00000468523, | ||
Fusion gene scores | * DoF score | 7 X 6 X 2=84 | 3 X 3 X 3=27 |
# samples | 7 | 3 | |
** MAII score | log2(7/84*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ELK4 [Title/Abstract] AND HDAC3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ELK4(205600759)-HDAC3(141007754), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ELK4 | GO:0070932 | histone H3 deacetylation | 22722849 |
Tgene | HDAC3 | GO:0000122 | negative regulation of transcription by RNA polymerase II | 16569215|18417529|18854353 |
Tgene | HDAC3 | GO:0001934 | positive regulation of protein phosphorylation | 25190803 |
Tgene | HDAC3 | GO:0006476 | protein deacetylation | 17172643|21030595 |
Tgene | HDAC3 | GO:0031647 | regulation of protein stability | 25190803 |
Tgene | HDAC3 | GO:0042307 | positive regulation of protein import into nucleus | 25190803 |
Tgene | HDAC3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 25190803 |
Tgene | HDAC3 | GO:0071498 | cellular response to fluid shear stress | 25190803 |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-YL-A8SK | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
Top |
Fusion Gene ORF analysis for ELK4-HDAC3 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000289703 | ENST00000305264 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
5UTR-3CDS | ENST00000357992 | ENST00000305264 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
5UTR-intron | ENST00000289703 | ENST00000469207 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
5UTR-intron | ENST00000357992 | ENST00000469207 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
intron-3CDS | ENST00000468523 | ENST00000305264 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
intron-intron | ENST00000468523 | ENST00000469207 | ELK4 | chr1 | 205600759 | - | HDAC3 | chr5 | 141007754 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ELK4-HDAC3 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for ELK4-HDAC3 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:205600759/:141007754) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | HDAC3 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Participates in the BCL6 transcriptional repressor activity by deacetylating the H3 'Lys-27' (H3K27) on enhancer elements, antagonizing EP300 acetyltransferase activity and repressing proximal gene expression. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required to repress transcription of the POU1F1 transcription factor. Acts as a molecular chaperone for shuttling phosphorylated NR2C1 to PML bodies for sumoylation (PubMed:21444723, PubMed:23911289). Contributes, together with XBP1 isoform 1, to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to endothelial cell (EC) survival under disturbed flow/oxidative stress (PubMed:25190803). Regulates both the transcriptional activation and repression phases of the circadian clock in a deacetylase activity-independent manner (By similarity). During the activation phase, promotes the accumulation of ubiquitinated ARNTL/BMAL1 at the E-boxes and during the repression phase, blocks FBXL3-mediated CRY1/2 ubiquitination and promotes the interaction of CRY1 and ARNTL/BMAL1 (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding (PubMed:28167758). In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response (PubMed:28167758). Interacts with SETD5 (By similarity). {ECO:0000250|UniProtKB:O88895, ECO:0000269|PubMed:21444723, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:25190803, ECO:0000269|PubMed:28167758}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ELK4-HDAC3 |
![]() |
Top |
Fusion Gene PPI Analysis for ELK4-HDAC3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ELK4-HDAC3 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | HDAC3 | O15379 | DB02546 | Vorinostat | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for ELK4-HDAC3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C0036341 | Schizophrenia | 4 | PSYGENET | |
Tgene | C0018799 | Heart Diseases | 1 | CTD_human |